Recently, MAN1A1 (MAN1C1 paralogue) was reported to be downregulated in CD133 + glioma stem cells, suggesting that high-mannose type N-glycan could be an enrichment signal for proneural GSC45. Here, MAN1C1 is linked to central nervous system cancer.